Kurma Partners

Kurma Partners is a European venture capital firm founded in 2009 and based in Paris, investing in healthcare and life sciences. Its stated purpose is to translate academic research into treatments for severe diseases and significant unmet medical needs, working with research teams and academic partners to evaluate discoveries, shape development plans and form companies around them. The firm manages approximately €890 million and reports having financed 72 companies and co-founded 25 since inception.

Investing spans company creation, early-stage venture and later growth, with dedicated vehicles for therapeutic biotechnology, for diagnostics, and for growth-stage healthcare opportunities. Sectors covered include therapeutic biotechnology, diagnostics, digital health and medical devices across Europe. Beyond capital, the firm contributes operating expertise and network to companies it helps create and to other early-stage businesses, and works alongside entrepreneurs, industry experts and academic institutions.

Governance arrangements include an ESG charter, signatory status for the UN Principles for Responsible Investment, and policies addressing impact, sustainability and medical bioethics.